US4495177A — Gel tableting agent

Claim 1

Independent Claim 131 words

A composition for a direct compression tableting agent comprising: a pharmacologically active mineral selected from the group consisting of iron, copper, aluminum, stannous, zinc and manganese; a binder solution comprising at least one gum product selected from the group consisting of Agar-Agar, Locust Bean, Tagacanth, gelatin and gum ghatti; and a substantially water insoluble compressible carrier comprising a mixture of about: 34% to 75% dicalcium phosphate anhydrous, 11% to 23% tricalcium phosphate, and 11% to 28% maltodextrin, said mineral and carrier being granulated together with said binder solution to form a mineral matrix granulation; and ascorbic acid blended with said mineral matrix granulation provided in a pharmacologically beneficial amount; whereby said mineral matrix granulation prevents substantial physical interaction between said mineral and said ascorbic acid such that reaction therebetween is minimized.

Claim 2

Dependent Claim 131 words

A composition for a direct compression tableting agent comprising: a pharmacologically active mineral selected from the group consisting of iron, copper, aluminum, stannous, zinc and manganese; a binder solution comprising at least one gum product selected from the group consisting of Agar-Agar, Locust Bean, Tagacanth, gelatin and gum ghatti; and a substantially water insoluble compressible carrier comprising a mixture of about: 34% to 75% dicalcium phosphate anhydrous, 11% to 23% tricalcium phosphate, and 11% to 28% maltodextrin, said mineral and carrier being granulated together with said binder solution to form a mineral matrix granulation; and ascorbic acid blended with said mineral matrix granulation provided in a pharmacologically beneficial amount; whereby said mineral matrix granulation prevents substantial physical interaction between said mineral and said ascorbic acid such that reaction therebetween is minimized.

Claim 3

Dependent Claim 34 words

The composition according to claim 1 wherein said mineral is a bioavailable iron supplement comprising ferrous fumarate containing at least 31.3% total iron of which not more than 2% is in the ferric state.

Claim 4

Dependent Claim 26 words

The composition according to claim 1 wherein said carrier comprising a mixture of dicalcium phosphate anhydrous, tricalcium phosphate and malto-dextrin in a ratio of about 6.6:1.1:1.0.

Claim 5

Dependent Claim 27 words

The composition according to claim 1 wherein said binder solution comprises about 0% to 15% Agar-Agar, 55% to 70% Acacia and 20% to 30% Locust Bean Gum.

Claim 6

Dependent Claim 37 words

The composition according to claim 4 wherein said binding solution comprises Agar-Agar, Acacia and Locust Bean Gum in a ratio of about 1.0:4.0:2.0 dispersed in an aqueous solution at a temperature of at least 75 degrees Centrigrade.

Claim 7

Dependent Claim 27 words

The composition according to claim 1 wherein said composition comprises a compressible granulation having a particle size in the range of about 100 microns to 200 microns.

Claim 8

Dependent Claim 107 words

A composition for an improved compression tableting agent wherein the improvement is the prevention of substantial reaction between ascorbic acid and iron in a tablet, comprising approximately by weight: (a) five parts iron matrix granulation comprising: (i) 1.5 parts ferrous fumarate, (ii) 13.3 parts water insoluble carrier comprising dicalcium phosphate anhydrous, tricalcium phosphate and maltodextrin in a weight ratio of about 6.6:1.1:1.0, and, (iii) 4 parts binding agent comprising Agar-Agar, Acacia and Locust Bean Gum in a ratio of about 1.0:4.0:2.0 dispersed in water at a temperature of at least 75 degrees Centrigrade; and (b) one part ascorbic acid, whereby said composition is compressible into a tablet.

Claim 9

Dependent Claim 107 words

A composition for an improved compression tableting agent wherein the improvement is the prevention of substantial reaction between ascorbic acid and iron in a tablet, comprising approximately by weight: (a) five parts iron matrix granulation comprising: (i) 1.5 parts ferrous fumarate, (ii) 13.3 parts water insoluble carrier comprising dicalcium phosphate anhydrous, tricalcium phosphate and maltodextrin in a weight ratio of about 6.6:1.1:1.0, and, (iii) 4 parts binding agent comprising Agar-Agar, Acacia and Locust Bean Gum in a ratio of about 1.0:4.0:2.0 dispersed in water at a temperature of at least 75 degrees Centrigrade; and (b) one part ascorbic acid, whereby said composition is compressible into a tablet.

Claim 10

Dependent Claim 120 words

A composition for an improved compression tableting agent comprising approximately by weight: (a) 493 parts iron matrix granulation comprising: (i) 1.5 parts ferrous fumarate, (ii) 10.0 parts dicalcium phosphate, anhydrous (iii) 1.7 parts tricalcium phosphate (iv) 1.6 parts malto-dextrin, (v) 0.3 parts beet powder, and (vi) 4.0 parts binding solution comprising by weight: (vii) 4.0 parts water at a temperature of at least 75 degrees C, (viii) 0.014 parts Agar-Agar, (ix) 0.056 parts Acacia, and (x) 0.028 parts Locust Bean Gum; (b) 81.0 parts ascorbic acid (c) 12.0 parts modified cellulose gum, (d) 1.0 parts barley flour, (e) 1.0 parts spinach powder, (f) 3.0 parts silica gel, (g) 3.0 parts partially hydrogenerated vegetable oil, and (h) 6.0 parts calcium stearate.

Claim 11

Dependent Claim 120 words

A composition for an improved compression tableting agent comprising approximately by weight: (a) 493 parts iron matrix granulation comprising: (i) 1.5 parts ferrous fumarate, (ii) 10.0 parts dicalcium phosphate, anhydrous (iii) 1.7 parts tricalcium phosphate (iv) 1.6 parts malto-dextrin, (v) 0.3 parts beet powder, and (vi) 4.0 parts binding solution comprising by weight: (vii) 4.0 parts water at a temperature of at least 75 degrees C, (viii) 0.014 parts Agar-Agar, (ix) 0.056 parts Acacia, and (x) 0.028 parts Locust Bean Gum; (b) 81.0 parts ascorbic acid (c) 12.0 parts modified cellulose gum, (d) 1.0 parts barley flour, (e) 1.0 parts spinach powder, (f) 3.0 parts silica gel, (g) 3.0 parts partially hydrogenerated vegetable oil, and (h) 6.0 parts calcium stearate.

Annuity Stage	Window Opens	Payment Deadline	Surcharge Period Until	Estimated Fee	Status
3.5 Years (Year 4)	1988-01-22	1988-07-23	1989-01-22	$2000.00	Window Closed / Lapsed
7.5 Years (Year 8)	1992-01-22	1992-07-23	1993-01-22	$3760.00	Window Closed / Lapsed
11.5 Years (Year 12)	1996-01-22	1996-07-23	1997-01-22	$7700.00	Window Closed / Lapsed

Gel tableting agent

Abstract

Inventors

Bibliographic Details

Claims Analysis

References Cited (Backward Citations)

USPTO Annuity & Maintenance Windows

Assigned Categories & Tags

Assign Category Tag